Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Novel laboratory-based therapeutic approach in AL amyloidosis: investigating FLC secretion

In this video, Giada Bianchi, MD, Brigham and Women’s Hospital & Dana-Farber Cancer Institute, Boston, MA, discusses ongoing research exploring mechanisms behind free light chain (FLC) secretion in light chain (AL) amyloidosis, and further comments on how this research may offer novel therapeutic options to patients with plasma cell disorders. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.